Inicio
Reels
Grupos
Páginas
Más
Grupos Páginas Mis blogs Mis ofertas Mis empleos Mis cursos Eventos Blogs Ofertas Empleos Cursos Foros Películas Juegos
Inicia sesión Registrarse
Modo día
TUDRIQEV Approval for Advanced Melanoma: Regulatory Progress, Mechanism, and Clinical Outlook
Replimune has reached an important milestone in oncology with the FDA’s accelerated approval of tudriqev (vusolimogene oderparepvec-wtpg), previously identified as RP1, in combination with Bristol Myers Squibb’s OPDIVO (nivolumab). Granted on August 6, 2026, the approval applies to adults with unresectable, advanced cutaneous melanoma that has progressed after treatment with an...
0 Commentarios ·0 Veces compartido ·195 Visualizaciones ·0 Reseñas
¡Inicia sesión para dar me gusta, compartir y comentar!
Villagge https://villagge.com